June 26, 2024
Riyadh, June 26th 2024,
Broadgate Advisers (“Broadgate”) has successfully advised Boston Oncology Arabia (the “Company”
or “BOA”), a leading bio-generic drugs manufacturing company based in Saudi Arabia, on a USD 35
million investment from TVM Capital Healthcare (“TVM”).
From its headquarters in Riyadh and production facility in Sudair Industrial City, BOA provides vital
medicines for critical conditions through the local development and manufacturing of internationally
licensed, best-in-class therapeutics. The Company is contributing to a key goal of Saudi Arabia’s
Vision 2030 by supplying critical care medicines through highly flexible, local manufacturing facilities
and leveraging its international relationships for licensing from Western and Eastern markets.
TVM will expedite BOA’s move into full formulation and fill and finish manufacturing, and will provide
strategic support and leverage its global network to further expand the Company’s access to
international suppliers.
Abdullah Baaj, MD, PharmD, Founder & CEO of BOA, commented: “Boston Oncology Arabia’s
localization model is specifically designed to create value in complex and competitive markets. TVM’s
investment enables us to strengthen our position and bring cutting-edge, specialized manufacturing
to the GCC and MENA region, impacting the lives of millions of patients.”
Orhan Osmansoy, Managing Partner at TVM Capital Healthcare, said: “As a fast-growing local biogenerics manufacturer, Boston Oncology Arabia is playing a major role in developing Saudi’s
pharmaceutical sector. With an impressive management team, the company is the established leader
in therapeutics for oncology and critical care. We are pleased to be on this journey with our coinvestors Kanoo Ventures, as Boston Oncology Arabia helps to increase local production, reduce
healthcare costs, and improve access to essential pharmaceuticals in the Kingdom.”
Habib Aoun, Head of M&A Advisory at Broadgate, added: “We are proud to have advised Boston
Oncology Arabia since its early stages of growth, leading up to this successful transaction with TVM.
The high level of interest generated from various strategic and financial investors throughout the
process demonstrated the strong global appetite for investments in Saudi Arabia in general, and in the
healthcare sector in particular.”
Boston Oncology Arabia
Boston Oncology Arabia, is a bio-generic drugs manufacturing company. with
headquarters in Riyadh and a production site in Sudair Industrial City, developing
internationally licensed specialty drugs locally (including generics and
biosimilars), supplying crucial medicines for critical illnesses.
TVM
TVM Capital Healthcare is an emerging markets-focused healthcare private
equity firm, headquartered in Dubai and Singapore, with offices in Riyadh and Ho
Chi Minh City and supporting offices in Munich and Boston. TVM invests in
expansionary and growth capital in healthcare companies improving local acess
to quality care and localy supply of medical products in the pharma, medical
device and diagnostics sectors.
About Broadgate
Broadgate Advisers is a subsidiary of Malta based BA Capital Holding PLC, a
group holding with subsidiaries active in M&A Advisory, Venture Capital and
Wealth Management. Broadgate maintains offices in Europe, Asia and the Middle
East.
Beirut, Lebanon – December 20, 2023 – Spinneys Levant Limited, the owner of the Spinneys, Happy
and Grab n’ Go brands in Lebanon (the “Group”), has successfully raised growth capital from Merit
SAL against a minority stake in the Group, for an undisclosed consideration.
The growth capital will be primarily used to enter and expand into the Iraq market.
Since its entry into the Lebanese market in 1948, Spinneys established itself as a pioneer in the mass
grocery retail sector in the country, being the first to introduce the concept of hypermarket. The
company operates the largest supermarket chain in Lebanon with one of the most recognized
brands, through a network of over 55 stores across the Lebanese territory, with various formats
including hypermarkets, supermarkets, discount stores and convenience stores.
Broadgate Advisers (No.23 on the CMA’ Financial Intermediaries List) acted as the financial advisor
to the seller in connection with this transaction.
